Clinical Research Shared Service
Clinical Research Shared Service
批准号:
7696610
负责人:
EDWARD A. SAUSVILLE
金额:
$15.19万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-08-08 至 2011-07-31
关键词:
AccountabilityAdverse eventAgreementAnnual ReportsApplications GrantsBaltimoreBasic ScienceBudgetsCalendarCancer CenterCancer Center Support GrantCancer and Leukemia Group BCase Report FormCategoriesChargeClinicalClinical DataClinical InvestigatorClinical ProtocolsClinical ResearchClinical TrialsCollectionConsentConsent FormsContractorContractsDataDatabasesDevelopmentDocumentationDoseDrug usageEducational CurriculumElementsEligibility DeterminationEnd PointEvaluationFundingGrantGuidelinesGynecologyHospital DepartmentsHospitalsHousingHuman ResourcesImageIndustryInformed ConsentInfusion proceduresIngestionInvestigational DrugsLaboratoriesLeadershipMarylandMediationMedicalMedical ResearchModificationMonitorNormal RangeOncology GroupPatientsPeer Review GrantsPharmaceutical PreparationsPharmacologyPharmacy facilityPhasePhase I Clinical TrialsPhase II Clinical TrialsPoliciesPrincipal InvestigatorProceduresProcessProtocols documentationQualifyingRadiationRadiation Therapy Oncology GroupRangeRecordsReportingResearchResearch DesignResearch Ethics CommitteesResearch PersonnelResourcesReview CommitteeSafetySamplingScheduleScoreSerious Adverse EventServicesSevere Adverse EventSite VisitSourceSystemTherapy Clinical TrialsTimeToxic effectU-Series Cooperative AgreementsUnderrepresented MinorityUnited States Food and Drug AdministrationUniversitiesWorkdemographicsdesigndosimetryhandbookmedical schoolsmemberprogramsquality assuranceresearch and developmentresearch studyresponsetreatment planning
中文摘要
临床研究共享服务
临床研究共享服务(CRSS)是人员、资源和流程的中心集合
支持临床方案的设计、开发和实施以及
审查委员会,包括马里兰大学医学院(UMSOM)的机构
审查委员会(IRB),适用于马里兰大学所有项目的临床研究人员
和斯图尔特·格林鲍姆癌症中心(UMGCC)。临床研究监督委员会提供
关于CRSS分配的资源的指导。CRSS促进了UMGCC之间的互动
基础科学研究人员和临床研究人员。中国社会科学院支持研究人员发起科学研究
他们的方案的审查,这是由UMGCC的临床研究委员会(CRC)在
协议被提交给IRB。对于没有外部数据安全监控(DSM)进程的协议,
CRSS还支持调查人员与UMGCC的DSM/质量保证进行互动
委员会(DSM/QAC)。
2008财政年度(2008财政年度),综合社会保障计划的预计预算总额为2,475,926元:581,315元(23%)
来自UMGCC基金的机构支持;来自马里兰大学的764,213美元(31%)
医疗系统;以及1,130,398美元(46%)来自同行评议赠款和工业试验。
自上一次UMGCC的核心拨款申请以来,CRSS已进行了广泛的修订:安装
新的领导层;正式确定了审查UMGCC协议应计费用的过程;修改了DSM/QAC
与IRB的审查同步的过程;致力于跟踪和促进
少数群体参与临床试验的服务不足;并获得和实施OnCore数据库,以
跟踪与不良事件和临床试验有关的人口统计学和里程碑事件。
在2007财年,UMGCC的有效和累积方案组合包括146项治疗试验和
65项非治疗性试验。社区服务中心使用约29.33名相当于全职工作人员的服务,包括
1名管理人员、15名研究协调员、5名数据管理人员或数据助理以及8.33名监管支助人员。
在07财年,242名新患者参加了治疗试验;704名新患者增加到
作为正在进行的研究的一部分,对2000多名患者进行了非治疗性试验。
英文摘要
Clinical Research Shared Service
The Clinical Research Shared Service (CRSS) is the central set of personnel, resources, and processes
that supports the design, development, and implementation of clinical protocols and interactions among
review committees, including the University of Maryland School of Medicine's (UMSOM's) Institutional
Review Board (IRB), for clinical investigators working in all programs at the University of Maryland Marlene
and Stewart Greenebaum Cancer Center (UMGCC). The Clinical Research Oversight Committee provides
guidance on resources that are apportioned by CRSS. CRSS facilitates interactions between UMGCC's
basic science investigators and clinical investigators. CRSS supports investigators in initiating the scientific
review of their protocols, which is performed by UMGCC's Clinical Research Committee (CRC) before the
protocol is submitted to the IRB. For protocols without an external Data Safety Monitoring (DSM) process,
the CRSS also supports investigators in their interactions with UMGCC's DSM/Quality Assurance
Committee (DSM/QAC).
For Fiscal Year 2008 (FY08), the total projected budget for CRSS is $2,475,926: $581,315 (23 percent)
from institutional support through UMGCC's funds; $764,213 (31 percent) from the University of Maryland
Medical System; and $1,130,398 (46 percent) from peer-reviewed grants and industrial trials.
The CRSS has been revised extensively since the last core grant application from UMGCC: installed
new leadership; formalized a process for reviewing accrual to UMGCC protocols; revamped the DSM/QAC
process that has been synchronized with reviews of the IRB; dedicated an effort to track and promote
underserved minority participation in clinical trials; and acquired and implemented the Oncore¿ database to
track demographics and milestones pertaining to adverse events and clinical trials.
For FY07, UMGCC's portfolio of active and accruing protocols included 146 therapeutic trials and
65 nontherapeutic trials. CRSS uses the services of approximately 29.33 full-time equivalents, including
1 manager, 15 research coordinators, 5 data managers or data assistants, and 8.33 regulatory support staff.
During FY07, 242 new patients were accrued to therapeutic trials; 704 new patients were accrued to
nontherapeutic trials; and more than 2,000 patients were being followed as part of ongoing research studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: TREATMENT OF MELANOMA WITH WILD-TYPE P53 AND A 100B USING PENTA
-
批准号:7951182
-
项目类别:
-
资助金额:$0.96万
-
财政年份:2009
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
UMGCC Paul Calabresi Clinical Oncology Training Program
-
批准号:8332885
-
项目类别:
-
资助金额:$106.57万
-
财政年份:2008
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
UMGCC Paul Calabresi Clinical Oncology Training Program
-
批准号:7928077
-
项目类别:
-
资助金额:$112.12万
-
财政年份:2008
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
UMGCC Paul Calabresi Clinical Oncology Training Program
-
批准号:7470184
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2008
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
Treatment of Melanoma with wild-type P53 and detectable S100B using pentamidine:
-
批准号:7529101
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2008
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
UMGCC Paul Calabresi Clinical Oncology Training Program
-
批准号:8141280
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2008
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
Treatment of Melanoma with wild-type P53 and detectable S100B using pentamidine:
-
批准号:7642487
-
项目类别:
-
资助金额:$31.13万
-
财政年份:2008
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
UMGCC Paul Calabresi Clinical Oncology Training Program
-
批准号:8548092
-
项目类别:
-
资助金额:$82.69万
-
财政年份:2008
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
UMGCC Paul Calabresi Clinical Oncology Training Program
-
批准号:7683191
-
项目类别:
-
资助金额:$70.81万
-
财政年份:2008
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
0629GCC: A PHASE I, OPEN-LABEL, MULTI-CENTER, DOSE-ESCALATION STUDY TO ASSESS SL
-
批准号:7608176
-
项目类别:
-
资助金额:$0.32万
-
财政年份:2007
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
0458GCC: A PHASE I DOSE ESCALATION STUDY OF INTRAVENOUS 17-AAG
-
批准号:7608152
-
项目类别:
-
资助金额:$4.07万
-
财政年份:2007
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
PHASE 1 OF SORAFENIB PLUS 17AAG IN SOLID TUMOR PATIENTS
-
批准号:7376971
-
项目类别:
-
资助金额:$2.03万
-
财政年份:2006
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
Protein Kinase Antagonists: Preclinical and Clinical
-
批准号:6558398
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
Protein Kinase Antagonists: Preclinical and Clinical
-
批准号:6433383
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
Clinical Protocol and Data Management
-
批准号:9145406
-
项目类别:
-
资助金额:$12.55万
-
财政年份:--
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
Immunotoxin Protocols Under the Medicine Branch: Targeted Therapy of Lymphoid Ne
-
批准号:6433124
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
Early Phase Clinical Research Support
-
批准号:9326171
-
项目类别:
-
资助金额:$13.91万
-
财政年份:--
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
IMMUNOTOXIN PROTOCOLS UNDER THE MEDICINE BRANCH: TARGETED THERAPY OF LYMPHOID NEO
-
批准号:6290777
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
Immunotoxin Protocols Under the Medicine Branch: Targete
-
批准号:6558377
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
PROTEIN KINASE ANTAGONISTS: PRECLINICAL AND CLINICAL
-
批准号:6290796
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:EDWARD A. SAUSVILLE
-
依托单位:
海外基金